Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Works matching IS 20412177 AND DT 2010 AND VI 2 AND IP 2
Results: 26
1
2
Ring and nodular multiple sclerosis lesions: a retrospective natural history study.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
3
Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2010, v. 2, n. 2, p. 57
- By:
- Publication type:
- Article
4
MRI criteria for MS in patients with clinically isolated syndromes.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
5
CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
6
Attenuation of experimental autoimmune encephalomyelitis in C57 BL/6 mice by osthole, a natural coumarin.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
7
Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
8
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
9
Rapid-onset central motor plasticity in multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
10
Preserved brain adaptive properties in patients with benign multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
11
Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
12
Combination therapy in multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
13
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
14
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
15
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
16
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
17
Non-adherence to interferon-beta therapy in Swedish patients with multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
18
Improving patient self-management of multiple sclerosis through a disease therapy management program.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
19
Carnitine for fatigue in multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
20
Novel forms of neurofascin 155 in the central nervous system: alterations in paranodal disruption models and multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
21
Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
22
High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseas.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
23
Oropharyngeal dysphagia in multiple sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
24
International Events 2010/11.
- Published in:
- 2010
- Publication type:
- Calendar
25
Optical Coherence Tomography as a Marker of Axonal Damage in Multiple Sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2010, v. 2, n. 2, p. 33
- By:
- Publication type:
- Article
26
Foreword.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2010, v. 2, n. 2, p. 1
- By:
- Publication type:
- Article